The Oncology Institute, Inc.

The Oncology Institute, Inc.

TOI·NASDAQ

$4.23

-7.8%
HealthcareMedical - Care Facilities

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

At a Glance

Live Snapshot
Market Cap$422.93M
EPS-0.5400
P/E Ratio-7.83
Earnings Date08/12/2026

toi

Common Stock

Last Annual Value

10.00K

3-Year CAGR

13%

5-Year CAGR

11%

10-Year CAGR

33%

The Oncology Institute, Inc.

The Oncology Institute, Inc. Competitors Analysis of Common Stock

TOI · NASDAQ
CompanyCommon Stock
CAGR 3Y
CAGR 5Y
CAGR 10Y
10.00K
7.7%7.4%N/A 
6.00K
0.0%3.7%19.6%
64.00K
1.1%7.3%N/A
0.00
N/AN/AN/A
1.00M
0.0%0.0%0.0%
6.00K
0.0%0.0%N/A
9.00K
8.7%5.2%6.1%
TALK logo
Talkspace, Inc.
NASDAQ:TALK
17.00K
2.0%2.5%N/A
74.00K
-36.0%-12.2%3.0%
41.00K
-57.4%-38.0%-8.0%
3.00K
-9.1%-5.6%0.0%
The Oncology Institute, Inc.

The Oncology Institute, Inc. Fair Value Envelope

TOI · NASDAQ

Our analysis suggests that TOI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.23, this represents a potential HIDDEN relative to our calculated worth for The Oncology Institute, Inc..

Intrinsic Value
Current Price: $4.23